Human Microbiome Market: Current Analysis and Forecast (2022-2028)

Report Description

Global Human Microbiome Market is expected to grow at a significant rate of around 26.7% during the forecast period. Human microbiome is a collection of microorganisms that live on or within the human body. These microbiomes have shown a potential role in healthcare owing to their multiple functions, including enabling easy digestion, regulation of the immune system, and production of vitamins. Studies have estimated that the number of microbes present inside the human body can be beneficial for the management of several diseases such as cancer and for adopting novel therapies. This presents lucrative opportunities for drug developers and vaccine manufacturers surging the growth of the human microbiome market. Several key companies are getting funds to fasten the process of development of therapeutic drugs. For instance, in 2022, OptiBiotix Health Plc. signed an exclusive sales and distribution agreement with Nahdi medical Co. to help tackle the obesity epidemic.

Enterome Biosciences SA, Yakult Honsha Co., 4D Pharma, Second Genome, Seres Therapeutics, Vedanta Biosciences, Inc., AOBiome, Microbiome Therapeutics LLC, and OptiBiotix HEALTH PLC. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst disease, cancer category to witness higher CAGR during the forecast period”

Based on disease, the market is segmented into obesity, infectious diseases, cancer, autoimmune diseases, metabolic & gastrointestinal disorders, and others. The cancer segment is expected to grow with high CAGR rates during the forecast period. It is attributed to the increase in incidences of cancer and the unmet need for targeted therapy. For instance, Enterome has developed OncoMimics, peptides derived from gut bacteria that mimic tumor-associated antigens in a wide range of cancers. The company’s lead candidate, EO2401 is being evaluated in a phase-I/II clinical trial in combination with an immune checkpoint inhibitor for the management of glioblastoma.

“Amongst product type, the probiotics to hold a significant share in the market in 2020”

On the basis of product, the market is categorized into probiotics, prebiotics, diagnostic tests, drugs, medical foods, supplements, and others. Among these, probiotics to hold a significant share of the market in 2020 which is due to the numerous health benefits offered by them. Furthermore, athletes and yoga instructors are also giving emphasis on the health benefits of probiotics through social media and paid partnerships. The segment has also received significant investment, which is another factor propelling the market growth. For instance, in February 2020, Amorepacific Group inaugurated its novel green tea probiotics Research Centre for studying lactobacillus found in Jeju organic green tea.

“Amongst application, diagnostics category to witness higher CAGR during the forecast period”

Based on application, the market is bifurcated into diagnostics and therapeutics. The diagnostic segment is expected to witness high CAGR rates during the forecast period which is due to the rise of scientific and technological innovations in gene mapping and the advent of omics technologies. The companies have also adopted strategic alliances to maintain a strategic edge in the global market. For instance, in June 2022, Genetic Analysis AS entered into collaboration with Servatus Biopharmaceuticals Ltd to advance microbiome diagnostics.

“North America to hold a significant share in the market”

In 2020, North America held a significant share of the global human microbiome market. Several factors, including surge in the prevalence of lifestyle-related disorders, increasing awareness among individuals regarding preventive healthcare, and the rise in research and development of human microbiome are driving the growth of the market in the region. Apart from this, the presence of major key players and the development of a strong pipeline of human microbiome products is also boosting the market’s growth. For instance, in 2020, Seres Therapeutics’ stool-derived treatment for recurrent Clostridium difficile infection cleared phase III of clinical trials.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global human microbiome market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Human Microbiome Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global Human Microbiome Market were the three major steps undertaken to create and analyze the adoption of human microbiomes in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global human microbiome market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the human microbiome market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the human microbiome market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product type, application, disease, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the human microbiome market. Further, we conducted factor analysis using dependent and independent variables such as various product type, application, disease, and distribution channel of human microbiome. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the human microbiome market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global human microbiome market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the human microbiome market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global human microbiome market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global human microbiome market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product type, application, disease, and distribution channel in the global human microbiome market.

The main objective of the Global CBD Oil Market Study

The current & future market trends of the global human microbiome market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the human microbiome market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of product type, application, disease, and distribution channel
• Define and analysis of the regulatory framework for the human microbiome industry.
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the human microbiome market for the major region.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
• Company profiles of the human microbiome market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team